Data / Form D filings / RxAnte, Inc.
RxAnte, Inc.: Form D filings
RxAnte, Inc., a health care company in Portland, ME, filed 3 Form D notices with the SEC between 2012 and 2022. The latest, on May 16, 2022, reports $10.9 million sold of a $10.9 million offering to 7 investors.
Find out what RxAnte, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 511 CONGRESS STREET, SUITE 803, Portland, ME, 04101
- Phone
- (703) 300-5459
- Industry
- Other Health Care
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1556197
The full lists. Form D filings in Maine: 101 rows, $5.05, or the new rows each week for $19 a month. Form D filings in Other Health Care: 1,958 rows, $97.90, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 16, 2022 | Amendment | $10,900,000 | $10,900,000 | $0 | 7 | Oct 8, 2020 | sec.gov |
| Oct 22, 2020 | New notice | $10,000,000 | $5,500,000 | $4,500,000 | 2 | Oct 8, 2020 | sec.gov |
| Sep 12, 2012 | New notice | $4,612,000 | $4,612,000 | $0 | 5 | Aug 29, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Mohit Kaushal | Director | |
| Nicholas Shapiro | Director | |
| Greg Lahens | Executive Officer | |
| Marc Wise | Executive Officer | |
| Brenton Burns | Director | |
| Joshua Benner | Executive Officer, Director | |
| Corbin Director | Executive Officer | |
| Eileen Casal | Executive Officer | |
| Jonathan Phillips | Director | |
| Loren Lidsky | Executive Officer | |
| Chronis Manolis | Director |
Every Form D from the week of May 16, 2022 · All recent filings in Maine · All recent Other Health Care filings
Read from SEC EDGAR. Amount sold is what RxAnte, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.